诺舒治疗子宫腺肌病30例临床疗效分析

发布时间：2018-02-10 17:29

本文关键词： 诺舒子宫腺肌病痛经月经过多　出处：《中南大学学报(医学版)》2016年01期 　论文类型：期刊论文

【摘要】：目的:探讨诺舒(Nova Sure)子宫内膜去除术治疗子宫腺肌病痛经合并月经过多的临床疗效及安全性。方法:对30例行诺舒治疗的子宫腺肌病痛经合并月经过多患者的临床资料进行回顾性分析,收集病例相关资料,通过门诊复诊或电话随访术后痛经、月经及贫血改善情况,比较手术前后B超子宫体积。结果:随访7~31个月,诺舒术后痛经缓解有效率83.3%,月经改善率为100%,贫血症状均明显好转,术后血红蛋白值比术前明显升高,差异有统计学意义(P0.05)。术后子宫体积较术前缩小,差异有统计学意义(P0.05)。术后2年内再次干预治疗1例(3.3%)。结论:诺舒用于治疗子宫腺肌病,既能解除月经过多症状又能使痛经症状明显缓解,是一种治疗子宫腺肌病的新方式。
[Abstract]:Objective: to investigate the clinical efficacy and safety of endometrial removal in the treatment of adenomyosis dysmenorrhea combined with menorrhagia. Methods: 30 patients with adenomyosis combined with menorrhagia were treated with Noushu. The bed data were analyzed retrospectively, The data of patients were collected, and the improvement of dysmenorrhea, menstruation and anemia were compared by follow-up or telephone follow-up. Results: the uterine volume of B-ultrasound was compared before and after operation. Results: the follow-up period was 7- 31 months. The effective rate of dysmenorrhea relief was 83.3%, menstrual improvement rate was 100%, anemia symptoms were obviously improved, the hemoglobin value after operation was significantly higher than that before operation, the difference was statistically significant (P 0.05). The uterine volume after operation was smaller than that before operation. The difference was statistically significant (P 0.05). One case of adenomyosis was treated again within 2 years after operation. Conclusion: the treatment of adenomyosis by Naoshu can relieve the symptoms of menorrhagia and relieve dysmenorrhea obviously. It is a new way to treat adenomyosis.
【作者单位】：中南大学湘雅三医院妇产科;青岛市立医院妇产科;
【分类号】：R711.71

【相似文献】